Haemodialysis (HD) patients are at risk of sarcopenia. Newer bioimpedance devices (BIS) using a three-compartmental body composition model, separate extracellular water overhydration from normo-hydrated lean tissue mass (LTM) and adipose tissue mass (ATM). During HD hydration status changes, along with changes in electrolytes and solutes, and may alter body composition measurements. As such, we measured BIS and serum osmotic pressure (sOP) pre-and post dialysis in 43 patients. There were no significant changes in LTM (39.5 ± 15.1 vs 39.3 ± 15.2 kg) or sOP (33.2 ± 8.3 vs 35.9 ± 9.7 mm Hg). Higher post-dialysis sOP was associated with a greater percentage fall in LTM (r = 0.43, P = 0.08) and increase in ATM (r = − 0.43, P = 0.017). Increased sOP post dialysis was associated with a reduction in LTM (r = 0.36, P = 0.033) and increased ATM (r = − 0.44, P = 0.013). Changes in sOP with HD are associated with changes in BIS body composition measurements. BIS measurements should preferably be made when patients are least overhydrated. (2017) 71, 564-565; doi:10.1038/ejcn.2016 published online 1 February 2017 Haemodialysis patients are at increased risk for sarcopenia, which is associated with increased mortality.
Haemodialysis patients are at increased risk for sarcopenia, which is associated with increased mortality. 1 The European Society for Parenteral and Enteral Nutrition guidelines recommend dual X-ray absorptiometry and bioimpedance assessments to detect muscle wasting. 2 Bioimpedance is more convenient than dual X-ray absorptiometry, and reports have shown equivalence in determining body composition. 3 Both methods typically divide the body into a twocompartmental model of fat and fat-free mass. However, assessments can be affected by hydration status. 4 Haemodialysis patients are volume overloaded pre-dialysis and fluid is removed during the dialysis session. Thus, post-dialysis measurements would potentially be more reliable when assessing muscle mass, but requires patients to remain behind after the dialysis session. More recently, a three-compartmental bioimpedance spectroscopy (BIS) model has been developed, separating extracellular water (ECW) over hydration from normally hydrated lean tissue mass (LTM) and normally hydrated adipose mass (ATM). 5 Potentially, this model would allow bioimpedance measurements of body composition to be made more conveniently pre-dialysis, as LTM and ATM should not change with removal of ECW excess. During haemodialysis, along with the change in ECW, there is also a change in electrolytes and serum osmolality, and as the bioimpedance model is based on the concept of measurement at a normo-hydrated state; we investigated whether body composition changes with dialysis 6 were associated with the changes in osmolality, as haemodialysis patients will differ not only in terms of hydration status but also electrolyte balance and uraemic solutes.
As part of clinical service development (UK NHS guidelines for clinical audit and service development (http://www.hra.nhs.uk/ documents/2013/09/defining-research.pdf), we measured serum osmotic pressure (sOP) in 43 haemodialysis patients, using a colloid osmometer (Osmomat 050, Genotec, San Francisco, CA, USA) and compared changes with pre-and post dialysis BIS (Body Composition Monitor, Fresenius AG, Bad Homburg, Germany), measured in a standardised manner, with electrodes placed in accordance with the manufacturer's instructions contra-laterally to fistulae, and post measurements delayed to allow for equilibration. 6, 7 Patient characteristics: 30 male (69.8%), mean age 64.5 ± 17.8 years, median dialysis session was 3.5 (3.0-4.0) hours, dialysate temperature 35.0 (35.0-35.4)°C, sodium 138 (137-140) mmol/l potassium 2.0 (1-2) mmol/l and ultrafiltration rate 8.1 ± 4.3 ml/kg/h. Weight and serum urea fell post dialysis, and there were no statistically significant overall changes in body composition (Table 1) . Calculated serum osmolality, using serum urea, sodium, potassium and glucose, fell from 314 ± 15.1 to 303.9 ± 10.0 mOsmol/kg, but no significant change in measured sOP (Table 1) . There was a correlation between measured predialysis sOP and calculated osmolality (r = 0.37, P = 0.04), and serum urea (r = 0.53, P = 0.001), but not between post-dialysis measurements. There was no correlation between pre-dialysis measured sOP and body composition or ECW status. The postdialysis measured sOP correlated with the percentage fall in total body water, intracellular water, LTM and negatively with ATM (Table 2 ). However, there was no correlation with the change in patient weight or ultrafiltration rate.
We then compared the change in sOP and changes in body composition. An increase in sOP post dialysis was associated with a fall in body cell mass (BCM), and LTM and negatively with ATM (Table 2) .
Although overall, the mean body composition values in terms of LTM, ATM and BCM measured with BIS did not significantly change post dialysis, at the individual patient level there were changes in body composition. Total body weight and serum urea fell post dialysis. Although there was a correlation between sOP and both serum urea concentration and calculated serum osmolality predialysis, there was no such correlation post dialysis. Standard equations for calculating serum osmolality are based on serum sodium, potassium, glucose and urea concentrations. Whereas measured sOP pre-dialysis would also include the other uraemic osmolytes and proteins, and then post dialysis, the competing effects of osmolyte clearances, changes in electrolytes and the effect of plasma water volume contraction. Depending upon the balance between the fall in osmolytes and plasma water contraction, sOP post dialysis increased in some patients and fell in others.
We found that the greater the post-dialysis sOP, the greater the percentage fall in intracellular water and total body water and also LTM, whereas ATM increased. There was no correlation between postdialysis sOP and either relative weight change or ultrafiltration rate.
Similarly, an increase in sOP post dialysis was associated with a reduction in LTM and BCM, and an increase in ATM. Conversely, when sOP decreased post dialysis, then LTM and BCM increased, and ATM fell. Previous bioimpedance studies have variously reported a fall in fat-free mass and increase in fat mass, or an increase in intracellular water and BCM. 8 Over estimation of fatfree mass has been ascribed to increased ECW pre-dialysis, as muscle contains more water than fat. In theory, as the three-compartmental model separates ECW excess from normally hydrated LTM and ATM, then there should be no changes in LTM or ATM following haemodialysis. However, the model is based on the concept of normally hydrated tissue, and tissue hydration will vary between haemodialysis patients due to hydration status, but also electrolyte balance and retention of uraemic solutes. During dialysis not only are there changes in hydration status but also electrolyte fluxes and removal of uraemic solutes, leading to differences in estimation of ECW and intracellular water during dialysis. 8, 9 As such, this will lead to changes in intracellular osmolality and cell hydration, which will vary between patients, leading to differences in tissue hydration status compared with the bioimpedance estimated normo-hydrated state. 10 However, as with any measuring device, there are error ranges for impedance predictions and some of the observed pre-post differences may be within these limits, although the changes we have demonstrated linked to osmolality would suggest an effect on BIS measurements.
We have demonstrated that using a three-compartmental model estimates of lean and adipose tissue mass change post dialysis, and that this is related in part to changes in osmotic pressure. Post dialysis, patients are less overhydrated, with a more normal electrolyte balance. Thus, for more reliable screening for sarcopenia and measurements of LTM, then bioimpedance measurements should preferably be made post dialysis.
